NOVIRA THERAPEUTICS
Novira Therapeutics is an antiviral drug discovery company that is focused on the discovery of first-in-class antiviral therapeutics for the treatment of chronic HBV and HIV infections, two global diseases with high levels of unmet need. Novira’s oral drugs target the capsid of the virus, and offer a promising treatment option both as monotherapy and in combination with current standards of care. The company’s antivirals potentially address limitations in treating chronic HBV infection, a di... sease for which the only class of oral drugs available, polymerase inhibitors, are rarely curative and often require lifelong treatment, as well as in chronic HIV infection, a disease for which the continued ability of the virus to mutate inevitably leads to drug-resistant viral strains. Each of these limitations to the standard of care can potentially be addressed by capsid inhibitors which feature a new mechanism of action.
NOVIRA THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2009-01-01
Address:
Radnor, Pennsylvania, United States
Country:
United States
Website Url:
http://www.noviratherapeutics.com
Total Employee:
11+
Status:
Closed
Contact:
(267)337-6913
Email Addresses:
[email protected]
Total Funding:
39.5 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Google Maps Microsoft Azure DNS Cloudflare DNS
Current Advisors List
Current Employees Featured
Founder
Investors List
BioAdvance
BioAdvance investment in Debt Financing - Novira Therapeutics
Versant Ventures
Versant Ventures investment in Series A - Novira Therapeutics
Robin Hood Ventures
Robin Hood Ventures investment in Series A - Novira Therapeutics
Mid Atlantic Angel Fund
Mid Atlantic Angel Fund investment in Series A - Novira Therapeutics
BioAdvance
BioAdvance investment in Series A - Novira Therapeutics
5AM Ventures
5AM Ventures investment in Series A - Novira Therapeutics
Delaware Crossing Investor Group
Delaware Crossing Investor Group investment in Series A - Novira Therapeutics
Canaan Partners
Canaan Partners investment in Series A - Novira Therapeutics
BioAdvance
BioAdvance investment in Seed Round - Novira Therapeutics
BioAdvance
BioAdvance investment in Venture Round - Novira Therapeutics
Official Site Inspections
http://www.noviratherapeutics.com
- Host name: ec2-54-247-102-104.eu-west-1.compute.amazonaws.com
- IP address: 54.247.102.104
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
